Leafly Holdings (Leafly Holdings) Days Sales Outstanding : 24.14 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Leafly Holdings Days Sales Outstanding?

Leafly Holdings's average Accounts Receivable for the three months ended in Mar. 2024 was $2.39 Mil. Leafly Holdings's Revenue for the three months ended in Mar. 2024 was $9.05 Mil. Hence, Leafly Holdings's Days Sales Outstanding for the three months ended in Mar. 2024 was 24.14.

The historical rank and industry rank for Leafly Holdings's Days Sales Outstanding or its related term are showing as below:

LFLY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.45 Med: 24.6 Max: 28.11
Current: 28.11

During the past 5 years, Leafly Holdings's highest Days Sales Outstanding was 28.11. The lowest was 22.45. And the median was 24.60.

LFLY's Days Sales Outstanding is ranked better than
73.44% of 640 companies
in the Healthcare Providers & Services industry
Industry Median: 46.995 vs LFLY: 28.11

Leafly Holdings's Days Sales Outstanding declined from Mar. 2023 (28.13) to Mar. 2024 (24.14).

Leafly Holdings Days Sales Outstanding Historical Data

The historical data trend for Leafly Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Leafly Holdings Days Sales Outstanding Chart

Leafly Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

22.45

25.09

24.11

25.63

Leafly Holdings Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial											28.13	30.89	30.17	28.30	24.14

Competitive Comparison of Leafly Holdings's Days Sales Outstanding

For the Pharmaceutical Retailers subindustry, Leafly Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Leafly Holdings's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Leafly Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Leafly Holdings's Days Sales Outstanding falls into.

Leafly Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Leafly Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3.298	+	2.635)	/	2 )	/	42.252	*	365
=	2.9665					/	42.252	*	365
=	25.63

Leafly Holdings's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (2.635	+	2.152)	/	2 )	/	9.048	*	365 / 4
=	2.3935					/	9.048	*	365 / 4
=	24.14

Leafly Holdings (NAS:LFLY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Leafly Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Leafly Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Leafly Holdings (Leafly Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Leafly Holdings Inc (NAS:LFLY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

113 Cherry Street, PMB 88154, Seattle, WA, USA, 98104-2205

Website

https://www.leafly.com

Leafly Holdings Inc operates an online cannabis information resource platform. It offers cannabis retailers and brands subscription-based marketplace listings that provide its cannabis audience with information, reviews, menus, and ordering and delivery options through legal retailers.

Executives

Yoko Miyashita	officer: CEO	C/O LEAFLY, 600 1ST AVE., STE LL20, SEATTLE WA 98104
Suresh Krishnaswamy	officer: CFO	C/O LEAFLY, 600 1ST AVE., STE LL20, SEATTLE WA 98104
Alan R Pickerill	director	C/O PORCH GROUP, INC., 411 1ST AVE S, STE. 501, SEATTLE WA 98104
Michael G. Blue	director	1920 EASTLAKE AVE E, SEATTLE WA 98102
Blaise Judja-sato	director	C/O LEAFLY, 111 SOUTH JACKSON STREET, SUITE 531, SEATTLE WA 98104
Chandler Cassandra Mcwilliams	director	C/O LEAFLY, 111 SOUTH JACKSON STREET, SUITE 531, SEATTLE WA 98104
David Cotter	officer: Chief Product Officer	C/O LEAFLY, 600 1ST AVE., STE LL20, SEATTLE WA 98104
Martin Samuel James Louis	officer: Chief Operating Officer	C/O LEAFLY, 600 1ST AVE., STE LL20, SEATTLE WA 98104
Lee Peter Ho Lik	director, officer: President, CFO	C/O MERIDA MERGER CORP. I, 641 LEXINGTON AVE, 18TH FLOOR, NEW YORK NY 10022
Brendan Kennedy	10 percent owner	1920 EASTLAKE AVENUE E., SEATTLE WA 98105
Merida Holdings, Llc	10 percent owner	C/O MERIDA MERGER CORP. I, 641 LEXINGTON AVE., 18TH FLOOR, NEW YORK NY 10022
Kimberly Boler	officer: General Counsel	C/O LEAFLY, 600 1ST AVE., STE LL20, SEATTLE WA 98104
Mitchell Baruchowitz	director	C/O MERIDA MERGER CORP. I, 641 LEXINGTON AVE, 18TH FLOOR, NEW YORK NY 10022
Jeffrey Monat	director	C/O MERIDA MERGER CORP. I, 641 LEXINGTON AVE., 18TH FLOOR, NEW YORK NY 10022
Andres Nannetti	director	C/O MERIDA MERGER CORP. I, 641 LEXINGTON AVE, 18TH FLOOR, NEW YORK NY 10022